The tablets will contain either Chlorella vulgaris or Chlorella sorokiniana, each incorporating a maximum of 10% additives. In the past the company said that using ‘pure’ one-strain
algae in tablet form was a challenge and would require about 60% additives. It said it had worked on this "query" since the establishment of the company back in 2012.
All the products – available in different shapes and sizes from 200 mg to 1000 mg – were free from yeasts, molds, bacterial inhibitors, other algae strains, heavy metals, PAH’s, iodine and pesticides.
The company said the single-strain tablets tapped into market demand for traceability.
It already produced capsules as part of its Essentials Health range, which also included powder.
Nutress manufactures algae for feed, food and pharma. Its Essentials Food range includes algae for use in pasta, bread, cakes and crackers.
Last month the company announced it would begin production of its second algae strain Chlorella vulgaris. A few weeks later it signed a distribution and NPD partnership with German firm Harke Pharma.